Deferiprone
- Generic Name
- Deferiprone
- Brand Names
- Ferriprox, Deferiprone Lipomed
- Drug Type
- Small Molecule
- Chemical Formula
- C7H9NO2
- CAS Number
- 30652-11-0
- Unique Ingredient Identifier
- 2BTY8KH53L
- Background
Deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011.
- Indication
Deferiprone is indicated in thalassemia syndromes when first line chelation agents are not adequate to treat transfusional iron overload.
- Associated Conditions
- Transfusional Iron Overload
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath